patvann/manage-uncontrolled-diabetes-hypothyroidism-cushings
patvann/manage-uncontrolled-diabetes-hypothyroidism-cushings
Target Population
Patients who have abnormal laboratory test results related to endocrinological conditions. Individuals with high Hemoglobin A1c (A1c) levels, abnormal Thyroid Stimulating Hormone (TSH) levels, or elevated 24-hour urine cortisol levels.
Recommendations
If a patient's A1c is greater than 9, or if their TSH or 24-hour urine cortisol levels are abnormal, they should be referred to their primary care provider (PCP) or a specialist, such as an endocrinologist.
Importance
Ensuring that patients with significant endocrine abnormalities receive timely and appropriate follow-up care. By systematically identifying and referring patients with abnormal lab results.
Conclusion
Automates the process of managing abnormal lab results related to endocrine disorders. It evaluates test results, determines if referrals are necessary, and updates the clinician’s workflow accordingly.
Resources
The Role of Clinical Care Pathways in Diabetes Management
A clinical care pathway guides clinicians in optimal treatment for specific conditions, aiming to improve care quality, reduce practice variation, and use resources efficiently. Based on evidence-based guidelines, these pathways outline recommendations for screening, diagnosis, monitoring, and treatment across the disease continuum, influencing care quality and outcomes, especially for chronic conditions like type 2 diabetes.
View Resource Paper